GMPS Antibody (1D10)

This product is produced by and distributed for Abnova, a company based in Taiwan.

In the de novo synthesis of purine nucleotides, IMP is the branch point metabolite at which point the pathway diverges to the synthesis of either guanine or adenine nucleotides. In the guanine nucleotide pathway, there are 2 enzymes involved in converting IMP to GMP, namely IMP dehydrogenase (IMPD1), which catalyzes the oxidation of IMP to XMP, and GMP synthetase, which catalyzes the amination of XMP to GMP.

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Showing Publication 1 - 1 of 1.

Publication using H00008833-M01	Applications	Species
da Costa AN, Mijal RS, Keen JN et al. Proteomic analysis of the effects of the immunomodulatory mycotoxin deoxynivalenol. Proteomics. 2011-03-09 [PMID: 21462343]

Array H00008833-M01

• GMPS Antibodies
• GMPS Lysate
• GMPS Proteins